Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1997; Volume 52,Issue 5

MINIREVIEW

  • You have access
    New Light on TRP and TRPL
    Craig Montell
    Molecular Pharmacology November 1997, 52 (5) 755-763; DOI: https://doi.org/10.1124/mol.52.5.755

Accelerated Communication

  • You have access
    Subtype-Specific Differences in Subcellular Localization of α1-Adrenoceptors: Chlorethylclonidine Preferentially Alkylates the Accessible Cell Surface α1-Adrenoceptors Irrespective of the Subtype
    Akira Hirasawa, Tatsuo Sugawara, Takeo Awaji, Keiko Tsumaya, Hiroshi Ito and Gozoh Tsujimoto
    Molecular Pharmacology November 1997, 52 (5) 764-770; DOI: https://doi.org/10.1124/mol.52.5.764

Articles

  • You have access
    Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
    Peter Cherepanov, José A. Esté, Robert F. Rando, Joshua O. Ojwang, Gunther Reekmans, Robert Steinfeld, Guido David, Erik De Clercq and Zeger Debyser
    Molecular Pharmacology November 1997, 52 (5) 771-780; DOI: https://doi.org/10.1124/mol.52.5.771
  • You have access
    The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating Agents
    Xiaofei Wang, Georg Nickenig and T. J. Murphy
    Molecular Pharmacology November 1997, 52 (5) 781-787; DOI: https://doi.org/10.1124/mol.52.5.781
  • You have access
    Ligand-Induced Phosphorylation, Clustering, and Desensitization of A1 Adenosine Receptors
    Francisco Ciruela, Carles Saura, Enric I. Canela, Josefa Mallol, Carmen Lluís and Rafael Franco
    Molecular Pharmacology November 1997, 52 (5) 788-797; DOI: https://doi.org/10.1124/mol.52.5.788
  • You have access
    Fludarabine-Mediated Repair Inhibition of Cisplatin-Induced DNA Lesions in Human Chronic Myelogenous Leukemia-Blast Crisis K562 Cells: Induction of Synergistic Cytotoxicity Independent of Reversal of Apoptosis Resistance
    Lan Li, Michael J. Keating, William Plunkett and Li-Ying Yang
    Molecular Pharmacology November 1997, 52 (5) 798-806; DOI: https://doi.org/10.1124/mol.52.5.798
  • You have access
    Ligand Binding Pocket of the Human Somatostatin Receptor 5: Mutational Analysis of the Extracellular Domains
    Michael T. Greenwood, Nedim Hukovic, Ujendra Kumar, Rosemarie Panetta, Siv A. Hjorth, Coimbatore B. Srikant and Yogesh C. Patel
    Molecular Pharmacology November 1997, 52 (5) 807-814; DOI: https://doi.org/10.1124/mol.52.5.807
  • You have access
    Evidence for Nucleotide Excision Repair as a Modifying Factor ofO 6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines
    Zhong-Ping Chen, Areti Malapetsa, Angela McQuillan, Daniela Marcantonio, Vanessa Bello, Gérard Mohr, Joanna Remack, Thomas P. Brent and Lawrence C. Panasci
    Molecular Pharmacology November 1997, 52 (5) 815-820; DOI: https://doi.org/10.1124/mol.52.5.815
  • You have access
    Phosphorylation of the Kv2.1 K+ Channel Alters Voltage-Dependent Activation
    Hideyuki Murakoshi, Gongyi Shi, Robert H. Scannevin and James S. Trimmer
    Molecular Pharmacology November 1997, 52 (5) 821-828; DOI: https://doi.org/10.1124/mol.52.5.821
  • You have access
    The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
    Gillian M. Greig, Donna A. Francis, Jean-Pierre Falgueyret, Marc Ouellet, M. David Percival, Patrick Roy, Christopher Bayly, Joseph A. Mancini and Gary P. O’Neill
    Molecular Pharmacology November 1997, 52 (5) 829-838; DOI: https://doi.org/10.1124/mol.52.5.829
  • You have access
    Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site
    Brian B. Hasinoff, Andrew M. Creighton, Hanna Kozlowska, Padmakumari Thampatty, William P. Allan and Jack C. Yalowich
    Molecular Pharmacology November 1997, 52 (5) 839-845; DOI: https://doi.org/10.1124/mol.52.5.839
  • You have access
    Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor
    John A. Auchampach, Xiaowei Jin, Tina C. Wan, George H. Caughey and Joel Linden
    Molecular Pharmacology November 1997, 52 (5) 846-860; DOI: https://doi.org/10.1124/mol.52.5.846
  • You have access
    N-Glycosylation Is Not a Prerequisite for Glutamate Receptor Function but Is Essential for Lectin Modulation
    Inga Everts, Carmen Villmann and Michael Hollmann
    Molecular Pharmacology November 1997, 52 (5) 861-873; DOI: https://doi.org/10.1124/mol.52.5.861
  • You have access
    Key Amino Acids in the γ Subunit of the γ-Aminobutyric AcidA Receptor that Determine Ligand Binding and Modulation at the Benzodiazepine Site
    Peter B. Wingrove, Sally A. Thompson, Keith A. Wafford and Paul J. Whiting
    Molecular Pharmacology November 1997, 52 (5) 874-881; DOI: https://doi.org/10.1124/mol.52.5.874
  • You have access
    Epirubicin-Induced Oxidative DNA Damage and Evidence for Its Repair in Lymphocytes of Cancer Patients Who Are Undergoing Chemotherapy
    Ryszard Olinski, Pawel Jaruga, Marek Foksinski, Karol Bialkowski and Jerzy Tujakowski
    Molecular Pharmacology November 1997, 52 (5) 882-885; DOI: https://doi.org/10.1124/mol.52.5.882
  • You have access
    Potentiation and Inhibition of Neuronal Nicotinic Receptors by Atropine: Competitive and Noncompetitive Effects
    Ruud Zwart and Henk P. M. Vijverberg
    Molecular Pharmacology November 1997, 52 (5) 886-895; DOI: https://doi.org/10.1124/mol.52.5.886
  • You have access
    Down-regulation of μ-Opioid Receptor by Full but Not Partial Agonists Is Independent of G Protein Coupling
    Nirmala Yabaluri and Fedor Medzihradsky
    Molecular Pharmacology November 1997, 52 (5) 896-902; DOI: https://doi.org/10.1124/mol.52.5.896
  • You have access
    Expression of Methylthioadenosine Phosphorylase cDNA inp16 −, MTAP −Malignant Cells: Restoration of Methylthioadenosine Phosphorylase-Dependent Salvage Pathways and Alterations of Sensitivity to Inhibitors of Purine de novo Synthesis
    Zhi-Hao Chen, Olufunmilayo I. Olopade and Todd M. Savarese
    Molecular Pharmacology November 1997, 52 (5) 903-911; DOI: https://doi.org/10.1124/mol.52.5.903
  • You have access
    Role of Free Radicals in Primary Nonfunction of Marginal Fatty Grafts from Rats Treated Acutely with Ethanol
    Zhi Zhong, Henry Connor, Robert F. Stachlewitz, Moritz von Frankenberg, Ronald P. Mason, John J. Lemasters and Ronald G. Thurman
    Molecular Pharmacology November 1997, 52 (5) 912-919; DOI: https://doi.org/10.1124/mol.52.5.912
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 52 (5)
Molecular Pharmacology
Vol. 52, Issue 5
1 Nov 1997
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • MINIREVIEW
  • Accelerated Communication
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics